nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—Skin necrosis—Melphalan—peripheral nervous system neoplasm	0.0723	0.0759	CcSEcCtD
Dobutamine—Skin necrosis—Cisplatin—peripheral nervous system neoplasm	0.0473	0.0497	CcSEcCtD
Dobutamine—Skin necrosis—Etoposide—peripheral nervous system neoplasm	0.0434	0.0455	CcSEcCtD
Dobutamine—Skin exfoliation—Tretinoin—peripheral nervous system neoplasm	0.0244	0.0257	CcSEcCtD
Dobutamine—Skin exfoliation—Isotretinoin—peripheral nervous system neoplasm	0.0244	0.0257	CcSEcCtD
Dobutamine—Skin necrosis—Epirubicin—peripheral nervous system neoplasm	0.0243	0.0255	CcSEcCtD
Dobutamine—Skin exfoliation—Melphalan—peripheral nervous system neoplasm	0.0241	0.0253	CcSEcCtD
Dobutamine—Skin necrosis—Doxorubicin—peripheral nervous system neoplasm	0.0225	0.0236	CcSEcCtD
Dobutamine—Phlebitis—Isotretinoin—peripheral nervous system neoplasm	0.0216	0.0227	CcSEcCtD
Dobutamine—Phlebitis—Tretinoin—peripheral nervous system neoplasm	0.0216	0.0227	CcSEcCtD
Dobutamine—Skin exfoliation—Alitretinoin—peripheral nervous system neoplasm	0.0185	0.0195	CcSEcCtD
Dobutamine—Phlebitis—Dactinomycin—peripheral nervous system neoplasm	0.0176	0.0185	CcSEcCtD
Dobutamine—Phlebitis—Alitretinoin—peripheral nervous system neoplasm	0.0164	0.0172	CcSEcCtD
Dobutamine—Skin exfoliation—Cisplatin—peripheral nervous system neoplasm	0.0158	0.0166	CcSEcCtD
Dobutamine—Skin exfoliation—Etoposide—peripheral nervous system neoplasm	0.0145	0.0152	CcSEcCtD
Dobutamine—Phlebitis—Cisplatin—peripheral nervous system neoplasm	0.0139	0.0146	CcSEcCtD
Dobutamine—Phlebitis—Etoposide—peripheral nervous system neoplasm	0.0128	0.0134	CcSEcCtD
Dobutamine—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.0109	0.0115	CcSEcCtD
Dobutamine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00989	0.0104	CcSEcCtD
Dobutamine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00989	0.0104	CcSEcCtD
Dobutamine—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00961	0.0101	CcSEcCtD
Dobutamine—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00953	0.01	CcSEcCtD
Dobutamine—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00953	0.01	CcSEcCtD
Dobutamine—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00941	0.00988	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Epirubicin—peripheral nervous system neoplasm	0.0094	0.00987	CcSEcCtD
Dobutamine—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00902	0.00947	CcSEcCtD
Dobutamine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00894	0.00939	CcSEcCtD
Dobutamine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00894	0.00939	CcSEcCtD
Dobutamine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00892	0.00936	CcSEcCtD
Dobutamine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00892	0.00936	CcSEcCtD
Dobutamine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00883	0.00927	CcSEcCtD
Dobutamine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.0088	0.00924	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Doxorubicin—peripheral nervous system neoplasm	0.0087	0.00913	CcSEcCtD
Dobutamine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00854	0.00896	CcSEcCtD
Dobutamine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00854	0.00896	CcSEcCtD
Dobutamine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00843	0.00885	CcSEcCtD
Dobutamine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00821	0.00862	CcSEcCtD
Dobutamine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00814	0.00855	CcSEcCtD
Dobutamine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00814	0.00855	CcSEcCtD
Dobutamine—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.00811	0.00851	CcSEcCtD
Dobutamine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00804	0.00844	CcSEcCtD
Dobutamine—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.0075	0.00788	CcSEcCtD
Dobutamine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.0075	0.00787	CcSEcCtD
Dobutamine—COMT—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.00737	0.155	CbGpPWpGaD
Dobutamine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00731	0.00768	CcSEcCtD
Dobutamine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00722	0.00758	CcSEcCtD
Dobutamine—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00715	0.00751	CcSEcCtD
Dobutamine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00678	0.00712	CcSEcCtD
Dobutamine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00676	0.00709	CcSEcCtD
Dobutamine—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00662	0.00695	CcSEcCtD
Dobutamine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00653	0.00686	CcSEcCtD
Dobutamine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00652	0.00684	CcSEcCtD
Dobutamine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00647	0.00679	CcSEcCtD
Dobutamine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00646	0.00679	CcSEcCtD
Dobutamine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00646	0.00679	CcSEcCtD
Dobutamine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00638	0.0067	CcSEcCtD
Dobutamine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00623	0.00655	CcSEcCtD
Dobutamine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00617	0.00648	CcSEcCtD
Dobutamine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00578	0.00606	CcSEcCtD
Dobutamine—Headache—Topotecan—peripheral nervous system neoplasm	0.00577	0.00606	CcSEcCtD
Dobutamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00576	0.00604	CcSEcCtD
Dobutamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00572	0.00601	CcSEcCtD
Dobutamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00572	0.00601	CcSEcCtD
Dobutamine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00564	0.00592	CcSEcCtD
Dobutamine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00561	0.00589	CcSEcCtD
Dobutamine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00551	0.00579	CcSEcCtD
Dobutamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00547	0.00574	CcSEcCtD
Dobutamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00543	0.0057	CcSEcCtD
Dobutamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00543	0.0057	CcSEcCtD
Dobutamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00536	0.00562	CcSEcCtD
Dobutamine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00529	0.00556	CcSEcCtD
Dobutamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00527	0.00554	CcSEcCtD
Dobutamine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00526	0.00552	CcSEcCtD
Dobutamine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00519	0.00545	CcSEcCtD
Dobutamine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00519	0.00545	CcSEcCtD
Dobutamine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00505	0.0053	CcSEcCtD
Dobutamine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0049	0.00514	CcSEcCtD
Dobutamine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00482	0.00506	CcSEcCtD
Dobutamine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.0048	0.00504	CcSEcCtD
Dobutamine—COMT—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.0047	0.0988	CbGpPWpGaD
Dobutamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00444	0.00466	CcSEcCtD
Dobutamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00434	0.00455	CcSEcCtD
Dobutamine—COMT—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.00419	0.0881	CbGpPWpGaD
Dobutamine—Headache—Vincristine—peripheral nervous system neoplasm	0.00418	0.00439	CcSEcCtD
Dobutamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00411	0.00432	CcSEcCtD
Dobutamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00396	0.00416	CcSEcCtD
Dobutamine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00382	0.00401	CcSEcCtD
Dobutamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.0035	0.00368	CcSEcCtD
Dobutamine—Headache—Etoposide—peripheral nervous system neoplasm	0.00339	0.00355	CcSEcCtD
Dobutamine—ADRB2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00338	0.0711	CbGpPWpGaD
Dobutamine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00328	0.00344	CcSEcCtD
Dobutamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00321	0.00337	CcSEcCtD
Dobutamine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00316	0.00332	CcSEcCtD
Dobutamine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00304	0.00319	CcSEcCtD
Dobutamine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00297	0.00311	CcSEcCtD
Dobutamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00296	0.0031	CcSEcCtD
Dobutamine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00292	0.00307	CcSEcCtD
Dobutamine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00283	0.00297	CcSEcCtD
Dobutamine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00274	0.00288	CcSEcCtD
Dobutamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00274	0.00287	CcSEcCtD
Dobutamine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.0027	0.00284	CcSEcCtD
Dobutamine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00262	0.00275	CcSEcCtD
Dobutamine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.0025	0.00262	CcSEcCtD
Dobutamine—ADRB1—Endothelin Pathways—COX2—peripheral nervous system neoplasm	0.00226	0.0475	CbGpPWpGaD
Dobutamine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00214	0.00225	CcSEcCtD
Dobutamine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00198	0.00208	CcSEcCtD
Dobutamine—Headache—Epirubicin—peripheral nervous system neoplasm	0.0019	0.00199	CcSEcCtD
Dobutamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.0018	0.00189	CcSEcCtD
Dobutamine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00184	CcSEcCtD
Dobutamine—ADRB2—Arf6 trafficking events—NME1—peripheral nervous system neoplasm	0.00173	0.0364	CbGpPWpGaD
Dobutamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.00175	CcSEcCtD
Dobutamine—ADRB1—Endothelin Pathways—GNAS—peripheral nervous system neoplasm	0.000963	0.0202	CbGpPWpGaD
Dobutamine—ADRB2—Arf6 signaling events—HGF—peripheral nervous system neoplasm	0.000856	0.018	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000782	0.0164	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00073	0.0153	CbGpPWpGaD
Dobutamine—ADRB2—Arf6 signaling events—MET—peripheral nervous system neoplasm	0.000675	0.0142	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.000644	0.0135	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00063	0.0132	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000561	0.0118	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000528	0.0111	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000517	0.0109	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000493	0.0104	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000433	0.00911	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00043	0.00904	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000405	0.00852	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000396	0.00833	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GNS—peripheral nervous system neoplasm	0.000382	0.00803	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—NME1—peripheral nervous system neoplasm	0.000366	0.00769	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GNS—peripheral nervous system neoplasm	0.000356	0.00749	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—COX2—peripheral nervous system neoplasm	0.000352	0.00741	CbGpPWpGaD
Dobutamine—CA2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000349	0.00734	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—NME1—peripheral nervous system neoplasm	0.000342	0.00718	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.000334	0.00702	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—COX2—peripheral nervous system neoplasm	0.000329	0.00691	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.000327	0.00686	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000308	0.00648	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000302	0.00634	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000296	0.00622	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000293	0.00615	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000289	0.00608	CbGpPWpGaD
Dobutamine—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000288	0.00606	CbGpPWpGaD
Dobutamine—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000282	0.00593	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GNS—peripheral nervous system neoplasm	0.000252	0.00531	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NME1—peripheral nervous system neoplasm	0.000242	0.00509	CbGpPWpGaD
Dobutamine—CA2—Metabolism—COX2—peripheral nervous system neoplasm	0.000233	0.0049	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ENO2—peripheral nervous system neoplasm	0.000231	0.00486	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ENO2—peripheral nervous system neoplasm	0.000216	0.00454	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GNS—peripheral nervous system neoplasm	0.000212	0.00445	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NME1—peripheral nervous system neoplasm	0.000203	0.00426	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—BCHE—peripheral nervous system neoplasm	0.000195	0.00411	CbGpPWpGaD
Dobutamine—COMT—Metabolism—COX2—peripheral nervous system neoplasm	0.000195	0.0041	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000186	0.00392	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—TH—peripheral nervous system neoplasm	0.000184	0.00386	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—BCHE—peripheral nervous system neoplasm	0.000182	0.00384	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000182	0.00383	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000178	0.00374	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000174	0.00366	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000174	0.00366	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—TH—peripheral nervous system neoplasm	0.000172	0.00361	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000171	0.00358	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000158	0.00333	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000155	0.00326	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000153	0.00322	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000152	0.00319	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GNAS—peripheral nervous system neoplasm	0.00015	0.00315	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000148	0.00312	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000147	0.00309	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GNAS—peripheral nervous system neoplasm	0.00014	0.00294	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000139	0.00291	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000137	0.00289	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000136	0.00285	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000132	0.00278	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000132	0.00277	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000129	0.00272	CbGpPWpGaD
Dobutamine—CA2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000129	0.00272	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000128	0.00269	CbGpPWpGaD
Dobutamine—CA2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000123	0.00259	CbGpPWpGaD
Dobutamine—CA2—Metabolism—TH—peripheral nervous system neoplasm	0.000121	0.00255	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000121	0.00255	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00012	0.00252	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000119	0.00249	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000117	0.00247	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000111	0.00233	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000108	0.00228	CbGpPWpGaD
Dobutamine—COMT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000108	0.00228	CbGpPWpGaD
Dobutamine—COMT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000103	0.00217	CbGpPWpGaD
Dobutamine—COMT—Metabolism—TH—peripheral nervous system neoplasm	0.000102	0.00214	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000101	0.00212	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GNAS—peripheral nervous system neoplasm	9.92e-05	0.00209	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.73e-05	0.00205	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NTS—peripheral nervous system neoplasm	9.35e-05	0.00197	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NTS—peripheral nervous system neoplasm	9.15e-05	0.00192	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.96e-05	0.00188	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.77e-05	0.00184	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GNAS—peripheral nervous system neoplasm	8.31e-05	0.00175	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ABCB1—peripheral nervous system neoplasm	8.16e-05	0.00171	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.83e-05	0.00165	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.66e-05	0.00161	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.11e-05	0.0015	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.09e-05	0.00149	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.96e-05	0.00146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.93e-05	0.00146	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.85e-05	0.00144	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.7e-05	0.00141	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.54e-05	0.00137	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.4e-05	0.00134	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.22e-05	0.00131	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.08e-05	0.00128	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.91e-05	0.00103	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.8e-05	0.00101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.32e-05	0.000909	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.23e-05	0.000889	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.2e-05	0.000883	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.11e-05	0.000864	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—peripheral nervous system neoplasm	4.05e-05	0.000851	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4e-05	0.000842	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.92e-05	0.000823	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—peripheral nervous system neoplasm	3.78e-05	0.000795	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.67e-05	0.000772	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.59e-05	0.000756	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—peripheral nervous system neoplasm	2.68e-05	0.000563	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.6e-05	0.000546	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.55e-05	0.000537	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.54e-05	0.000534	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.5e-05	0.000525	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—peripheral nervous system neoplasm	2.24e-05	0.000472	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.02e-05	0.000424	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.97e-05	0.000415	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.9e-05	0.0004	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.86e-05	0.000391	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.85e-05	0.000389	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.83e-05	0.000385	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.81e-05	0.00038	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.79e-05	0.000377	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.68e-05	0.000353	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.64e-05	0.000345	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.54e-05	0.000323	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.5e-05	0.000316	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.43e-05	0.000301	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.4e-05	0.000294	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.17e-05	0.000247	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.15e-05	0.000242	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.12e-05	0.000236	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.1e-05	0.000231	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.92e-06	0.000208	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.7e-06	0.000204	CbGpPWpGaD
